Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Effectiveness of ICD therapy in real clinical practice. The Olomouc ICD Registry

M. Taborsky, T. Skala, M. Fedorco, V. Doupal, I. Sovova, J. Jarkovsky, K. Benesova, M. Bezdekova, M. Vicha, J. Danek, J. Kautzner

. 2023 ; 167 (3) : 225-235. [pub] 20211217

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23018203

BACKGROUND: Clinical parameters linked to a low benefit of ICD implantation and increased mortality risks are needed for an individualized assessment of potential benefits and risks of ICD implantation. METHODS: Analysis of a prospective registry of all patients hospitalized from 2009 to 2019 in a single centre for a first implantation of any type of ICD. RESULTS: A total of 2,681 patients were included in the registry. Until the end of follow-up (38.4 ± 29.1 months), 682 (25.4%) patients died. The one-year mortality in all patients, the one-year CV mortality, the three-year mortality in all patients, and the three-year CV mortality were 7.8%, 5.7%, 20.6%, and 14.8%, respectively. There was a statistically significant difference when the subgroups were compared according to the type of cardiomyopathy. No significant difference was found between primary and secondary prevention and between the types of devices. Male gender, age ≥ 75 years, diabetes mellitus, and atrial fibrillation were associated with a significantly increased mortality risk. CONCLUSION: In an analysis of a long-term follow-up of 2,681 ICD patients, we found no mortality difference between patients with ischemic or non-ischemic cardiomyopathy and in the device type. A higher mortality risk was found in men, patients older than 75 years, diabetics, and those with atrial fibrillation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23018203
003      
CZ-PrNML
005      
20231121092148.0
007      
ta
008      
231107s2023 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2021.071 $2 doi
035    __
$a (PubMed)34916673
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Táborský, Miloš, $u Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Olomouc, Czech Republic $d 1962- $7 jn20010310074
245    10
$a Effectiveness of ICD therapy in real clinical practice. The Olomouc ICD Registry / $c M. Taborsky, T. Skala, M. Fedorco, V. Doupal, I. Sovova, J. Jarkovsky, K. Benesova, M. Bezdekova, M. Vicha, J. Danek, J. Kautzner
520    9_
$a BACKGROUND: Clinical parameters linked to a low benefit of ICD implantation and increased mortality risks are needed for an individualized assessment of potential benefits and risks of ICD implantation. METHODS: Analysis of a prospective registry of all patients hospitalized from 2009 to 2019 in a single centre for a first implantation of any type of ICD. RESULTS: A total of 2,681 patients were included in the registry. Until the end of follow-up (38.4 ± 29.1 months), 682 (25.4%) patients died. The one-year mortality in all patients, the one-year CV mortality, the three-year mortality in all patients, and the three-year CV mortality were 7.8%, 5.7%, 20.6%, and 14.8%, respectively. There was a statistically significant difference when the subgroups were compared according to the type of cardiomyopathy. No significant difference was found between primary and secondary prevention and between the types of devices. Male gender, age ≥ 75 years, diabetes mellitus, and atrial fibrillation were associated with a significantly increased mortality risk. CONCLUSION: In an analysis of a long-term follow-up of 2,681 ICD patients, we found no mortality difference between patients with ischemic or non-ischemic cardiomyopathy and in the device type. A higher mortality risk was found in men, patients older than 75 years, diabetics, and those with atrial fibrillation.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a senioři $7 D000368
650    12
$a fibrilace síní $7 D001281
650    _2
$a rizikové faktory $7 D012307
650    _2
$a náhlá srdeční smrt $x prevence a kontrola $7 D016757
650    12
$a kardiomyopatie $x terapie $7 D009202
650    _2
$a registrace $7 D012042
650    12
$a defibrilátory implantabilní $7 D017147
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
700    1_
$a Skála, Tomáš $u Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Olomouc, Czech Republic $7 xx0137536
700    1_
$a Fedorco, Marián $u Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Olomouc, Czech Republic $7 xx0160964
700    1_
$a Doupal, Vlastimil $u Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Olomouc, Czech Republic $7 xx0018903
700    1_
$a Sovová, Ingrid $u Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Olomouc, Czech Republic $7 xx0104858
700    1_
$a Jarkovský, Jiří, $u Institute of Health Information and Statistics of the Czech Republic, Praha, Czech Republic $u Institute of Biostatistics and Analyses at the Faculty of Medicine of the Masaryk University (IBA FM MU) in Brno, Czech Republic $d 1976- $7 stk2008461294
700    1_
$a Benešová, Klára $u Institute of Health Information and Statistics of the Czech Republic, Palackeho nam. 4,Praha 2, Czech Republic $u Institute of Biostatistics and Analyses at the Faculty of Medicine of the Masaryk University (IBA FM MU) in Brno, Czech Republic $7 xx0224941
700    1_
$a Bezdekova, Monika $u Institute of Health Information and Statistics of the Czech Republic, Praha, Czech Republic
700    1_
$a Vícha, Marek $u Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Olomouc, Czech Republic $7 xx0229304
700    1_
$a Daněk, Josef $u Department of Cardiology, Central Military Hospital Prague, Czech Republic $7 xx0242063
700    1_
$a Kautzner, Josef, $u Institute for Clinical and Experimental Medicine, Czech Republic $d 1957- $7 xx0037112
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1804-7521 $g Roč. 167, č. 3 (2023), s. 225-235
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34916673 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y p $z 0
990    __
$a 20231107 $b ABA008
991    __
$a 20231121092145 $b ABA008
999    __
$a ok $b bmc $g 2011504 $s 1204606
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 167 $c 3 $d 225-235 $e 20211217 $i 1804-7521 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK198 $a Pubmed-20231107

Najít záznam

Citační ukazatele

Možnosti archivace